Somatotropin-releasing hormone (1-43), also known as growth hormone-releasing hormone (GHRH), is a synthetic form of the naturally occurring hormone that stimulates the pituitary gland to release growth hormone (GH). It is mainly used in diagnostic testing to assess pituitary function and growth hormone deficiency. In some cases, it may also be used therapeutically to treat GH deficiency, particularly in children or adults with specific medical conditions. The (1-43) form refers to the full-length active peptide sequence responsible for its biological activity. The directory classifies it as a commercial API with a peptide source/manufacturing origin. Other names for this substance include Rgrf 43 and Rhgrf(1-43). Its PubChem CID is 16132356.
Somatotropin releasing hormone (1-43)
| CAS No | 86472-71-1 |
|---|---|
| Molecular Formula | C225H360N76O67S |
| Molecular Weight | 5234 g/mol |
| Synonyms | (4S)-4-[[2-[[(2S)-5-amino-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-5-amino-2-[[2-[[(2S)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-3-(1H-imidazol-5-yl)propanoyl]amino]propanoyl]amino]-3-carboxypropanoyl]amino]propanoyl]amino]-3-methylpentanoyl]amino]-3-phenylpropanoyl]amino]-3-hydroxybutanoyl]amino]-3-hydroxypropanoyl]amino]-3-hydroxypropanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-5-carbamimidamidopentanoyl]amino]-5-carbamimidamidopentanoyl]amino]-3-methylpentanoyl]amino]-4-methylpentanoyl]amino]acetyl]amino]-5-oxopentanoyl]amino]-4-methylpentanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]propanoyl]amino]-5-carbamimidamidopentanoyl]amino]hexanoyl]amino]-4-methylpentanoyl]amino]-4-methylpentanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]amino]-4-carboxybutanoyl]amino]-3-methylpentanoyl]amino]-4-methylsulfanylbutanoyl]amino]-3-carboxypropanoyl]amino]-5-carbamimidamidopentanoyl]amino]-5-oxopentanoyl]amino]-5-oxopentanoyl]amino]acetyl]amino]-5-[[(2S)-1-[[(2S)-4-amino-1-[[(2S)-5-amino-1-[[(2S)-1-[[(2S)-5-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(1S)-3-amino-1-carboxy-3-oxopropyl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-4-carboxy-1-oxobutan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-1,4-dioxobutan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-5-oxopentanoic acid |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Somatotropin-releasing hormone (1-43), also known as growth hormone-releasing hormone (GHRH), is a synthetic form of the naturally occurring hormone that stimulates the pituitary gland to release growth hormone (GH).
The listed CAS number is 86472-71-1.
The listed molecular formula is C225H360N76O67S.
The listed molecular weight is 5234 g/mol.
The source lists Rgrf 43 and Rhgrf(1-43).
It is listed as a commercial API with a peptide origin.